Skip to content

Health benefits of Millets

Clinical validation of traditional millet recipes (roti/dosa/khichidi) in maintaining healthy intestinal microbial flora and preventing lifestyle associated complications

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079130
Enrollment
60
Registered
2025-01-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified Health Condition 2: E08-E13- Diabetes mellitus Health Condition 3: I51- Complications and ill-defined descriptions of heart disease

Interventions

Intervention1: Millet Diet: Traditional breakfast millet recipes (roti/dosa/khichidi) for 3 months Intervention2: Dietary Intervention: Millet diet-induced changes in Gut microbiota and biomarkers in

Sponsors

Department of Science and Technology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Group 1: Healthy volunteers -Normal (without type II diabetes mellitus (TY2DM), Cardiovascular Disease (CVD)/hypertension, Non-alcoholic fatty liver disease (NAFLD) /hyperlipidemia), Volunteers with following conditions: Group 2: type II diabetes mellitus (TY2DM)/prediabetes, Group 3: Cardiovascular Disease (CVD)/hypertension, Group 4: Non-alcoholic fatty liver disease (NAFLD) /hyperlipidemia) will be included in this study. The participants who are on medications for the above conditions will also be included.

Exclusion criteria

Exclusion criteria: People with severe illnesses, People already on a millet diet, Those with gastrointestinal symptoms and/or gastrointestinal diseases, Pregnant or lactating females and Those who have recently (past month) used antibiotics will be excluded from this study.

Design outcomes

Primary

MeasureTime frame
All participants will be subjected to analysis of changes in following biomarkers in blood sample analysis before and after millet intake- Diabetic/ prediabetic markers (Fasting Blood Sugar) CVD biomarkers (complete lipid profile, adiponectin, C-Reactive Protein, Angiotensin Converting Enzyme activity) Hepatic functions (Aspartate aminotransferase, Alanine transaminase, Alkaline phosphatase, Albumin, Bilirubin, Total protein, Gamma glutamyl transferase) Analysis of the gut microflora by 16S rRNA sequencing of stool samples before and after the millet intakeTimepoint: First and last day of the 3 months period of millet diet.

Secondary

MeasureTime frame
Beneficial effects of millets on the gut microbiome as evidenced by increase in gut microflora. Identification of newer disease management strategies to improve patient health outcome via dietary changes.Timepoint: First and last day of the 3 months period of millet diet.

Countries

India

Contacts

Public ContactDr Priya S

CSIR National Institute for Interdisciplinary Science and Technology

priyasulu@gmail.com8606135606

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026